Cohera Medical, Inc. has received Priority Review Status Designation from the US FDA for its Sylys® Surgical Sealant
Intra-arterial stroke treatment was significantly more effective than medical management with tissue plasminogen activator (tPA), the current standard of care.
It looks like the company has been working hard with the FDA as they've agree to allow expedited patient enrollment
French orthopaedic imaging specialist EOS imaging, tells us that the U.S. FDA has approved hipEOS, 3D hip arthroplasty planning software based on EOS stereo-radiographic 2D/3D imaging.
Whatever the value of retrospective data, Boston Scientific is touting results that make a solid case for its Precision Spectra spinal cord stimulator system
CeloNova BioSciences, Inc., is celebrating solid results from a First-in-Man clinical trial of its COBRA PzF™ coronary stent system.
Newly FDA approved, additional Attain Performa® Quadripolar Leads deliver more options so physicians can optimize delivery of Cardiac Resynchronization Therapy
New CE approval extends to the revision of dialysis access vessels.
UK NHS Watchdog NICE is consulting on draft guidance on a device that avoids surgical biopsy as it aims to diagnose and monitor liver damage.
Royal Philips and Volcano Corporation are set to merge in a deal worth approximately $1 Billion.
A new paper suggests that TissuePatchDural film is at least as effective as gel-based approaches to adjunctive dural closure following neurosurgery.
FDA cleared back in October, Medtronic is now to launch its Novashield, Chitosan-Based material for use in Functional Endoscopic Sinus Surgery.
Stimwave's pain management device can be programmed to reduce patient perception, making it possible to perform a sham-controlled study for the first time.
The German TAVI peddlers reckon Trinity's a world beating "third generation" device. And now it can be delivered transfemorally.
Quadra Allure MP™ CRT-P expands the St. Jude Medical heart failure portfolio and is supported by newly presented data that demonstrate an increase in patient response to multipoint pacing therapy